Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cardiovascular disease

Certolizumab Pegol Drug Studies Find No New Safety Issues

Michele B. Kaufman, PharmD, BCGP  |  March 1, 2015

Plus, updates on clazakizumab, hydrocodone bitartrate extended-release capsules and other rheumatology drug news, safety information

Filed under:Drug Updates Tagged with:Certolizumab PegolclazakizumabdrugFDAhydrocodone bitartrateKaufmanrheumatologySafety

Glucocorticoid Use in Rheumatoid Arthritis Management Focus of Ongoing Debate

Gretchen Henkel  |  March 1, 2015

Questions around prescribing steroids as bridge therapy, in long-term low dosages, or low-dose timed-release formulas, or not at all evoke controversy among rheumatologists

Filed under:ConditionsDrug UpdatesRheumatoid Arthritis Tagged with:ArthritisdebateglucocorticoidHenkelrheumatologistSteroidtherapy

Drug Interactions for Trimethoprim/ Sulfamethoxazole Come to Light

Michele B. Kaufman, PharmD, BCGP  |  February 1, 2015

Plus, updates on buprenorphine, diclofenac sodium, secukinumab and other rheumatology drug news, safety information

Filed under:AnalgesicsDrug Updates Tagged with:drugFDAinteractionKaufmanrheumatologySafety

2014 ACR/ARHP Annual Meeting: Lupus Nephritis

Mary Beth Nierengarten  |  February 1, 2015

Multi-targeted, aggressive drug therapies needed for complete response, remission of this lupus complication

Filed under:ConditionsMeeting ReportsSystemic Lupus Erythematosus Tagged with:2014 ACR/ARHP Annual MeetingAC&RAssociation of Rheumatology Professionals (ARP)drugLupus nephritis

Nurses’ Health Study Continues to Offer Valuable Patient Data

Susan Bernstein  |  January 1, 2015

Nurses’ cohort of 38 years provides wealth of patient information, research for rheumatologists

Filed under:ConditionsResearch RheumRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:BernsteinDiseaseLupusNurses' Health Studypatient dataResearchRheumatoid arthritisrheumatology

Hydrocodone Bitartrate, Secukinumab, Varenicline Updates, Trials, Approvals

Michele B. Kaufman, PharmD, BCGP  |  December 1, 2014

Plus, rheumatology drug news, safety updates

Filed under:AnalgesicsAxial SpondyloarthritisConditionsDrug UpdatesResearch RheumRheumatoid Arthritis Tagged with:Ankylosing SpondylitisApprovalsdrugFDAhydrocodone bitartrateKaufmanlabsPainResearchRheumatoid arthritisrheumatologysecukinumabvarenicline

Sugary Soft Drinks Can Raise Risk of Rheumatoid Arthritis

Richard Quinn  |  November 21, 2014

Study finds consuming one or more sugar-sweetened sodas daily can increase women’s chance of developing seropositive RA by more than 60%

Filed under:ConditionsResearch RheumRheumatoid Arthritis Tagged with:Rheumatoid arthritisrisk

How Wars Have Shaped Rheumatology

Simon M. Helfgott, MD  |  November 1, 2014

Treating sick, injured soldiers has taught physicians lessons about fighting infections, cancer

Filed under:OpinionRheuminationsSpeak Out Rheum Tagged with:CancerHelfgottHistoryReactive arthritisrheumatologistrheumatologyTreatment

Inflammatory Origin of Fever Is Key to Diagnosis

Simon M. Helfgott, MD  |  September 1, 2014

Fever in rheumatology patients may present evidence of an inflammatory process

Filed under:ConditionsGout and Crystalline ArthritisOpinionOther Rheumatic ConditionsRheuminationsSpeak Out RheumSystemic Lupus Erythematosus Tagged with:braincrystal arthritisfeverGoutHelfgottimagingInfectioninflammatorymicrobepatient carerheumatologistSarcoidosisSystemic lupus erythematosus

Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss

Michele B. Kaufman, PharmD, BCGP  |  August 1, 2014

Plus, rheumatology drug news from EULAR 2014

Filed under:Axial SpondyloarthritisConditionsDrug UpdatesEULAR/OtherMeeting ReportsPsoriatic ArthritisRheumatoid Arthritis Tagged with:AC&RAmerican College of Rheumatology (ACR)Ankylosing Spondylitisanti-inflammatorydrugEULARInternationalKaufmanMethotrexatePsoriatic ArthritisRheumatoid arthritisrheumatologistrheumatologySafetytocilizumabweight loss

  • « Previous Page
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • …
  • 64
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences